Immix Biopharma Inc. (IMMX)

AI Score

Unlock

1.81

0.06 (3.43%)

At close: Apr 25, 2025, 10:53 AM

Immix Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net Income	-21.69M	-21.96M	-19.16M	-18.36M	-15.53M	-14.24M	-11.43M	-9.4M	-8.23M	-27.19M	-26.05M	-24.7M	-24.38M	-2.39M	-2.11M	-2.03M	-1.15M	-382.29K	-265.96K	-132.98K
Depreciation & Amortization	115.39K	77.13K	52.6K	28.81K	5.47K	2.96K	2.14K	2.02K	2.13K	2.19K	2.24K	2.48K	2.47K	2.43K	2.39K	2.35K	2.32K	1.74K	1.16K	580.00
Stock-Based Compensation	3.02M	3.37M	3.37M	3.18M	2.57M	1.74M	1.17M	788.91K	524.07K	416.13K	314.8K	279.81K	218.98K	96.83K	34.97K	4.25K	n/a	n/a	n/a	n/a
Other Working Capital	4.74M	2.97M	2.75M	1.25M	-391.25K	-2.39M	-2.26M	-627.73K	-826.31K	-169.04K	-355.95K	-675.02K	-284.97K	248.47K	247.05K	259.69K	285.88K	54.7K	53.69K	26.84K
Other Non-Cash Items	928.22K	1.53M	2.14M	1.61M	866.1K	295.42M	294.86M	296.02M	295.76M	624.31K	594.43K	-2.19K	118.16K	676.54K	665.2K	505.08K	303K	-272K	-280.79K	-140.39K
Deferred Income Tax	n/a	-668.67K	-1.27M	-738.02K	-931.97K	-295.42M	-294.81M	-295.35M	-295.16M	22.11M	22.11M	22.02M	22.85M	735K	735K	825K	n/a	n/a	n/a	n/a
Change in Working Capital	3.97M	2.8M	967.43K	2.11M	1.65M	-105.89K	-765.63K	499.29K	195.21K	-79.21K	331.89K	-478.17K	-391.04K	567.06K	341.17K	278.45K	446.63K	97.7K	53.69K	26.84K
Operating Cash Flow	-14.6M	-15.8M	-14.85M	-13.11M	-11.37M	-12.6M	-10.97M	-8.01M	-7.41M	-4.62M	-3.21M	-2.82M	-1.59M	-316.28K	-337.24K	-425.19K	-404.69K	-563.63K	-491.91K	-245.95K
Capital Expenditures	-1.18M	-683.71K	-451.08K	-354K	-52.09K	-38.91K	n/a	n/a	n/a	802.00	802.00	802.00	n/a	-802	-802	-802	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-52.09K	-52.09K	-52.09K	-52.09K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.18M	-683.71K	-451.08K	-354K	-52.09K	-38.91K	-2.91M	-2.91M	-2.91M	-2.91M	802.00	802.00	n/a	-802	-802	-802	n/a	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	100K	200K	200K	200K	100K	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-44K	-44K	-99.96K	-99.96K	-55.96K	-55.96K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	2.49K	5.11K	-53.69K	-244.51K	-232K	233.66K	3.21M	3.35M	3.33M	21.58M	18.65M	18.68M	18.65M	-71.02K	-52.67K	-35K	n/a	n/a	n/a	n/a
Financial Cash Flow	15.95M	16.54M	26.6M	31.29M	15.46M	15.3M	8.15M	3.35M	6.15M	24.44M	21.51M	21.7M	18.85M	128.98K	147.33K	65K	n/a	n/a	n/a	n/a
Net Cash Flow	172.17K	108.01K	11.32M	17.86M	4.07M	2.67M	-5.75M	-7.6M	-4.21M	16.88M	18.29M	18.88M	17.25M	-150.04K	-143.41K	-313.22K	-342.93K	-545.98K	-480K	-240K
Free Cash Flow	-15.77M	-16.48M	-15.3M	-13.46M	-11.42M	-12.64M	-10.97M	-8.01M	-7.41M	-4.62M	-3.21M	-2.82M	-1.59M	-317.08K	-338.04K	-425.99K	-404.69K	-563.63K	-491.91K	-245.95K